Koike K, Aono T, Miyake A, Tsutsumi H, Matsumoto K, Kurachi K
Fertil Steril. 1981 Feb;35(2):138-41. doi: 10.1016/s0015-0282(16)45312-4.
Bromocriptine is known to be effective in the treatment of women with hyperprolactinemic anovulation or amenorrhea-galactorrhea. A new schedule of combined treatment with bromocriptine and clomiphene citrate was applied to 23 patients with normoprolactinemic amenorrhea who failed to respond to clomiphene alone. Ovulation was restored by treatment in 14 of these patients (60.9%), resulting in pregnancy in 3 women. Treatment resulted in immediate suppression of serum prolactin levels and a gradual increase in serum luteinizing hormone levels and estradiol levels followed by a luteinizing hormone surge. The present results indicate that bromocriptine/clomiphene combination therapy is effective in the treatment of amenorrheic patients with normoprolactinemia who do not respond to clomiphene alone, and suggest that bromocriptine restores the responsiveness of the hypothalamic-pituitary-ovarian system to clomiphene.
已知溴隐亭对治疗高催乳素血症性无排卵或闭经-溢乳的女性有效。一种溴隐亭与枸橼酸氯米芬联合治疗的新方案应用于23例单独使用氯米芬无效的正常催乳素血症性闭经患者。这些患者中有14例(60.9%)经治疗恢复排卵,3名女性怀孕。治疗导致血清催乳素水平立即受到抑制,血清黄体生成素水平和雌二醇水平逐渐升高,随后出现黄体生成素高峰。目前的结果表明,溴隐亭/氯米芬联合疗法对单独使用氯米芬无效的正常催乳素血症性闭经患者有效,并提示溴隐亭可恢复下丘脑-垂体-卵巢系统对氯米芬的反应性。